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How Do the Virulence Factors of
Shigella Work Together to Cause
Disease?
Emily Mattock and Ariel J. Blocker *
Faculty of Biomedical Sciences, Schools of Cellular and Molecular Medicine and Biochemistry, University of Bristol,
Bristol, UK
Shigella is the major cause of bacillary dysentery world-wide. It is divided into four
species, named S. flexneri, S. sonnei, S. dysenteriae, and S. boydii, which are distinct
genomically and in their ability to cause disease. Shigellosis, the clinical presentation
of Shigella infection, is characterized by watery diarrhea, abdominal cramps, and fever.
Shigella’s ability to cause disease has been attributed to virulence factors, which are
encoded on chromosomal pathogenicity islands and the virulence plasmid. However,
information on these virulence factors is not often brought together to create a detailed
picture of infection, and how this translates into shigellosis symptoms. Firstly, Shigella
secretes virulence factors that induce severe inflammation and mediate enterotoxic
effects on the colon, producing the classic watery diarrhea seen early in infection.
Secondly, Shigella injects virulence effectors into epithelial cells via its Type III Secretion
System to subvert the host cell structure and function. This allows invasion of epithelial
cells, establishing a replicative niche, and causes erratic destruction of the colonic
epithelium. Thirdly, Shigella produces effectors to down-regulate inflammation and the
innate immune response. This promotes infection and limits the adaptive immune
response, causing the host to remain partially susceptible to re-infection. Combinations of
these virulence factorsmay contribute to the different symptoms and infection capabilities
of the diverse Shigella species, in addition to distinct transmission patterns. Further
investigation of the dominant species causing disease, using whole-genome sequencing
and genotyping, will allow comparison and identification of crucial virulence factors and
may contribute to the production of a pan-Shigella vaccine.
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INTRODUCTION
Shigella was recognized as the causative agent of bacillary dysentery in 1897 by Kiyoshi Shiga. He
determined that it was a Gram negative bacillus, which was capable of fermenting dextrose, but
was indole-reaction negative and incapable of producing acid from mannitol (Trofa et al., 1999).
Shigella is a non-sporulating, facultative anaerobe. Shigella is also a primate-restricted pathogen,
which differentiates it from the other members of the Enterobacteriaceae family in which it is
classified.
The Shigella genus is divided into four species: Shigella dysenteriae (serogroup A, 15 serotypes),
Shigella flexneri (serogroup B, 19 serotypes), Shigella boydii (serogroup C, 20 serotypes), and
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Shigella sonnei (serogroup D, 1 serotype). These are divided
into multiple serotypes dependent on O-antigen and biochemical
differences. Different species are linked to disease in varying
geographical locations. S. dysenteriae causes severe epidemic
disease in less developed countries, S. flexneri causes disease
in developing countries, S. boydii is confined to the Indian
subcontinent, and S. sonnei occurs in both transitional and
developed countries (Levine et al., 2013).
Shigellosis is the clinical presentation of Shigella infection.
Disease is transmitted through the fecal-oral route, with an
infectious dose of only 10–100 organisms (Levine et al., 2013).
After 1–4 days, infection is acute, non-systemic and enterically
invasive, leading to destruction of the colonic epithelium
(detailed in Figure 1). Damage along the colonic epithelial is
dramatic but erratic, and leads to the main clinical symptom
of diarrhea, containing blood and sometimes mucus, which
may be accompanied by abdominal cramps and fever. Further
complications, depending on the infecting Shigella species and
host HLA subtype, includeHaemolytic-Uremic Syndrome (HUS)
and Post-Reactive Arthritis (WHO, 2005). HUS occurs in 2–
7% of S. dysenteriae type 1 infections, whereby the Shiga toxin
harbored by this species attaches to the endothelium and activates
platelets, which adhere to the endothelium and occlude blood
vessels leading microangiopathic haemolysis of red blood cells
as they squeeze through the restricted blood vessel lumen
(O’Loughlin and Robins-Browne, 2001). Symptoms include acute
renal failure, thrombocytopenia, micro-angiopathic haemolytic
anemia, with a 35% fatality rate (Mayer et al., 2012). Post-reactive
arthritis is another complication of Shigella infection, occurring
in 2% of cases, and is characterized by painful joints, painful
urination, and irritation of eyes, with chronic arthritis lasting
from months to years.
Comparison of the main subtypes of these species by Yang
et al. (2005) indicates that each Shigella species contains a
single circular chromosome and a virulence plasmid. The
virulence plasmid has been thoroughly researched in relation
to pathogenesis, and the majority of the important virulence
factors involved in the Shigella life-cycle are localized to a 30
kb region termed the “entry region” (Figure 2). This region
contains themxi-spa locus, which encodes the Type III Secretion
System (T3SS), and ipa and ipg genes, which are essential for
invasion of epithelial cells and initiation of Shigella infection.
In addition to the virulence plasmid, distinct regions within
the Shigella chromosome have also been shown to contribute
to infection. These are termed “pathogenicity islands” (PAI)
(Table 1), which are unstable transferable elements that can be
found in a variety of combinations depending on the Shigella
species and subtype (Yang et al., 2005). A combination of both
chromosomal virulence factors and plasmid virulence factors
mediate the Shigella life cycle that leads to destruction of the
colonic epithelium and disease symptoms.
The T3SS harbored by Shigella is pivotal to infection,
delivering from the bacterial cytoplasm into the host cell effectors
that play a role in cellular invasion, manipulation, and apoptosis
(Parsot, 2009). At 37◦C the T3SS components are assembled
(Figure 3) but secretion of effectors is prevented until the T3SS is
activated by contact with the host cell (Veenendaal et al., 2007).
FIGURE 1 | Infectious cycle of Shigella (Roerich-Doenitz, 2013)
modified from Schroeder and Hilbi (2008). Entry into the colonic epithelium
is mediated in two ways: M-cell membrane ruffling, and epithelial barrier
destabilization. Entry via M-cells is achieved through membrane ruffling (1),
and the bacillus is then transported to the M-cell pocket, where it is
endocytosed by resident macrophages (2). Epithelial barrier destruction is
mediated by pro-inflammatory (IL-1) and chemotaxic cytokines (IL-8). IL-8
produced by neighboring epithelial cells recruits PMN leukocytes (12), which
travel from the basolateral to the apical colonic epithelium, destabilizing the
junctions between the epithelial cells and allowing further invasion of Shigella
(5). Induction of pyroptotic macrophage death occurs after Shigella escape
from the phagocytic vacuole (3 and 6). Caspase-1, when activated, cleaves
and activates IL-1β and IL-18, leading to the release of these pro-inflammatory
cytokines (4) (Jennison and Verma, 2004). Uptake of Shigella is a
macropinocytic process at the basolateral membrane of epithelial cells (7).
Stimulation of Rho-family GTPases triggers actin polymerisation and then
depolymerization, forming filopodial and lamellipodial extensions of the
epithelial membrane, leading to engulfment of the bacilli. Lysis of the
macropinocytic vacuole allows Shigella to gain access to the epithelial
cytoplasm, where it rapidly multiplies, escapes autophagy and fragments the
Golgi (8 and 9). Exploitation of the epithelial actin assembly machinery allows
Shigella to move both intra- and intercellularly (10). Protrusions mediated by
bacilli are actively endocytosed by the clathrin-mediated endocytic pathways
at intercellular junctions, and the double membrane vacuole is lysed to give
Shigella access to the neighboring cells cytoplasm (11). PMN leukocytes
eventually eliminate Shigella infection from the colonic epithelium (13).
These effectors can be classified dependent on the timing of gene
expression as either early, middle, or late effectors, and unless
stated otherwise, all of the effectors discussed below are encoded
on the virulence plasmid and secreted in a T3SS-dependent
manner (Table 2).
Dysentery, the main clinical symptom of shigellosis, is
due to the infectious cycle of Shigella and its ability to
penetrate and colonize the colonic epithelium, leading to loss
of barrier function and inflammation (Jennison and Verma,
2004). This initial inflammation (Figure 1) is paramount for
efficient infection. However, Shigella must also overcome this
innate immune response and dampen inflammation in order
to establish infection, especially in the epithelial cell niche.
Shigella diminishes the inflammatory response by delivering
effectors to inhibit the NFκB and MAPK signaling pathways
and epigenetically regulate the repression of pro-inflammatory
cytokines such as IL-8 (Ashida et al., 2011). In addition,
Shigella is capable of downregulating production of antimicrobial
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 March 2017 | Volume 7 | Article 64
Mattock and Blocker Shigella Virulence Factor Function
FIGURE 2 | Genomic organization of the entry region on plasmid pWR100 (Roerich-Doenitz, 2013). Genes are clustered in two operons, the ipa/ipg and the
mxi/spa operon. They are colored in the legend according to their protein class, some of which, such as T3SS effectors, are detailed in the text. Secretion machinery
refers to the components that build the T3SS. Translocators are components of the translocon, a pore inserted into the host membrane to allow effector translocation
and chaperones are components that stabilize individual effectors prior to secretion from the bacterium. Regulators modulate T3SS expression and function but they
are largely beyond the scope of this review. This figure was modified from the virulence plasmid map by Buchrieser et al. (2000).
TABLE 1 | Genes and protein functions involved in virulence on the
Shigella chromosome.
PAI Gene(s) Protein function References
SHI-1 sigA Putative enterotoxin Al-Hasani et al., 2009
pic Intestinal colonization Navarro-Garcia et al.,
2010
set1A,
set1B
ShET1 enterotoxin Fasano et al., 1997
SHI-2 iucA–D Siderophore, complexes
with iron
Vokes et al., 1999
iutA Bacterial receptor for
iron-siderophore complex
Vokes et al., 1999
shiA–G Novel ORFS, ShiA involved
in reduction in host
inflammatory response
Ingersoll et al., 2003
SHI-3 iucA–D Siderophore, complexes
with iron
Purdy and Payne, 2001
iutA Bacterial receptor for
iron-siderophore complex
Purdy and Payne, 2001
SHI-O gtrA,
gtrB, gtr
Serotype conversion and
O-antigen modification
Allison and Verma,
2000
Stx-phage P27 stxAB Shiga toxin Yang et al., 2005
peptides, including human β-defensin hBD-3, and chemokines,
such as CCL20, leading to defective dendritic cell recruitment
(Sperandio et al., 2008). This allows for increased replication,
efficient infection of neighboring cells, and evasion of the
immune response (Figure 1). Eventually, however, the initial
inflammatory response which allows for efficient infection
consequently leads to Shigella clearance. Polymorphonuclear
leukocytes (PMN), such as neutrophils, eliminate the infection
within 5–7 days in healthy individuals (Figure 1).
Shigella has evolved to successfully re-infect its host and
probably subverts the production of efficient immunological
memory to do so. After infection, seroconversion produces
protective antibodies against Shigella lipopolysaccharide (LPS),
FIGURE 3 | Schematic drawing of the Shigella Type III Secretion
System (Roerich-Doenitz, 2013). The architecture of Shigella T3SS is based
on the virulence plasmid mxi-spa locus (Figure 2), which encodes proteins
that produce the T3SS apparatus, a structure composed of a 60 nm hollow
extracellular needle, a transmembrane domain, and a cytoplasmic bulb
(Blocker et al., 1999).
however the antibodies produced are serogroup specific. The
diversity of Shigella LPS serotypes means that protection
against re-infection is limited to homologous disease, and these
LPS-specific antibodies are also short lasting (Cohen et al.,
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TABLE 2 | Effectors secreted in a T3SS-dependent manner.
Effectors Early/Middle/
Late
Enzyme activity Function References
IcsB Early Inhibits autophagy Allaoui et al., 1992; Ambrosi et al., 2014; Baxt and Goldberg,
2014; Huang and Brumell, 2014; Campbell-Valois et al., 2015
IpaA Early Actin depolymerization Tran Van Nhieu et al., 1997; Bourdet-Sicard et al., 1999; Izard
et al., 2006; Ramarao et al., 2007
IpaB Early Translocon pore formation High et al., 1992; Thirumalai et al., 1997; Page et al., 1999;
Skoudy et al., 2000; Lafont et al., 2002; Yang et al., 2013;
Suzuki et al., 2014b
IpaC Early Translocon pore formation; Actin
polymerization; Docking and effector
induction.
Bârzu et al., 1997; Tran Van Nhieu et al., 1999; Osiecki et al.,
2001; Terry et al., 2008; Mounier et al., 2009; Du et al., 2016;
Russo et al., 2016
IpaD Early Activation of T3SS Blocker et al., 1999; Arizmendi et al., 2016
IpaH0722 E3 ubiquitin ligase Ubiquitinates TRAF2 Ashida et al., 2013
IpaH7.8 Late E3 ubiquitin ligase Ubiquitinates glomulin Suzuki et al., 2014a
IpaH9.8 Late E3 ubiquitin ligase Ubiquitinates U2AF35 and NEMO/IKKγ Okuda et al., 2005; Ashida et al., 2010
IpaJ Cysteine protease Cleaves ARF1-GTP Burnaevskiy et al., 2015; Dobbs et al., 2015
IpgB1 Early GEF Activates Rac1 and Cdc42 Ohya et al., 2005; Hachani et al., 2007; Huang et al., 2009
IpgB2 Early GEF Activates RhoA Hachani et al., 2007; Huang et al., 2009; Klink et al., 2010
IpgD Early Inositol 4-phosphatase Converts PtdIns(4,5)P2 to PtdIns(5)P Niebuhr et al., 2000; Mayo and Donner, 2001; Mellouk et al.,
2014; Garza-Mayers et al., 2015
OspB Middle Phosphorylation of ERK and p38 MAPK Zurawski et al., 2009; Ambrosi et al., 2014; Lu et al., 2015
OspC1 Middle Phosphorylation of ERK Zurawski et al., 2006
OspC3 Early Binds p19 Kobayashi et al., 2013
OspD3 Late Enterotoxic activity Farfán et al., 2011; Faherty et al., 2016
OspE1/2 Late Adhesin Interacts with ILK Miura et al., 2006; Kim et al., 2009; Faherty et al., 2012a
OspF Middle Phosphothr-eonine lyase Dephosphorylates MAPKs Arbibe et al., 2007; Li et al., 2007; Zhu et al., 2007
OspG Late Kinase Inhibits SCFβ−TrCP ubiquitinating IκBα Kim et al., 2005; Zhou et al., 2013; Grishin et al., 2014;
Pruneda et al., 2014
OspI Glutamine deamidase Deamidates UBC13 Sanada et al., 2012; Nishide et al., 2013
OspZ1–188 Phosphorylation of ERK Newton et al., 2010
OspZ Blocks p65 nuclear translocation Zurawski et al., 2008; Nadler et al., 2010
VirA Middle GAP Inactivates Rab proteins Germane et al., 2008; Dong et al., 2012; Campbell-Valois
et al., 2015
1991). Progressive acquisition of pan-species immunological
memory occurs after many infections, and is probably achieved
through recognition of protein-based specific antigens, such
as the “invasion plasmid antigens” (Ipa) proteins. These
virulence plasmid-encoded antigens are therefore important
targets for vaccine development (Levine et al., 2013). The
adaptive immune response, including T- and B-lymphocytes,
takes 4–7 days to begin working efficiently, which coincides
with resolution of Shigella infection in healthy individuals.
Shigella prevents dendritic cell recruitment by downregulating
the main chemoattractant CCL20, as previously described, and
alsomediates dendritic cell apoptosis (Kim et al., 2008). Dendritic
cells are a key link between the innate and adaptive immune
response, and the inhibition of their function consequently
interferes with the TH1-TH2-TH17 transition required for an
efficient adaptive immune response (Sperandio et al., 2008).
Therefore, it is possible that prevention of an efficient adaptive
immune response is achieved via a combination of innate
immune system modulation and subversion of immunological
memory production.
The individual virulence factors of Shigella have been
compiled and reviewed previously. Here we aim to understand
how they collaborate to cause acute enteric destruction, leading
to the clinical manifestation of shigellosis. We will analyse
the available primary data for the function of Shigella effector
proteins and their effect on host cells, and then discuss how these
are co-ordinated in time and space to create a detailed picture
of Shigella infection, how it leads to disease and manipulates the
immune response.
ANALYSIS
Epithelial Barrier Destabilization and
Inflammation
OspB: Promotes PMN Migration, Inflammation, and
Cell Proliferation
Like most effectors, OspB is found in the four Shigella
species, and has homolog in Salmonella species (Zurawski
et al., 2009). Although its biochemical function is unknown,
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it is thought that OspB plays a role in the activation of
extracellular-signal-regulated kinases (ERK) and p38 MAPK
pathways, resulting in phosphorylation of phospholipase A2
and the generation of eicosanoids. OspB is capable of nuclear
localization for activation of MAPK signaling pathways. This
contributes to inflammation and PMN migration, possibly
inducing hepoxilin A3, an arachidonic acid derivative, and apical
secretion of IL-8, a PMN chemoattractant (Ambrosi et al., 2014).
An ospB− mutant had a 60% decrease in PMN migration and
a 30% decrease in ERK1/2 activation 90 min post-infection
when compared to wild-type Shigella (Zurawski et al., 2009).
Furthermore, Ambrosi et al. (2014) showed that an ospB−
knockout displayed significantly reduced onset and severity
of symptoms in the guinea pig keratoconjunctivitis model of
infection (Sereny test). However, OspB also activates the master
regulator of cell growth mTOR via a direct interaction with
the cellular scaffold protein IQGAP1, which also interacts with
mTOR activators ERK1/2. This seems to restricts the spread
of S. flexneri in cell monolayers, possibly by enhancing cell
proliferation in infected foci (Lu et al., 2015).
OspC1: Promotes PMN Migration and Inflammation
OspC1 is part of the ospC family. There is 96% identity between
ospC2, ospC3, and ospC4, but only 74% identity between these
three ospC genes and ospC1 (Buchrieser et al., 2000). This
level of similarity may indicate redundancy. However, ospC4
is a pseudogene and different functions have been identified
for OspC1 and OspC3 (discussed later). Tagged OspC1 is
found throughout the host cytoplasm, localizing primarily to
the nucleus (Zurawski et al., 2006). An ospC1− knockout
showed a significant decrease in the amount of neutrophil
recruitment to the epithelial cells in PMN migration assays,
which was restored to wild-type levels on complementation
with a plasmid expressing ospC1. Zurawski et al. (2006) showed
that this increase in PMN migration correlated with increase in
the phosphorylation of ERK1/2 pathways mediated by OspC1.
An ospC1− knockout showed a decrease in phosphorylation of
ERK1/2 compared to wild-type levels but no reduction in IL-
8 secretion. OspC1 plays a role in Shigella virulence in vivo
as an ospC1− knockout had reduced amounts of swelling and
inflammation in the Sereny test, with clearance of infection after
2 days (Zurawski et al., 2006).
OspZ: Promotes PMN Migration and Inflammation
In S. flexneri 2a, an ospZ− knockout has no effect on the
Sereny test. However, an ospZ− knockout caused a significant
decrease in PMN migration. The knockout also had 63 and
53% ERK1/2 phosphorylation and NFκB activation, respectively,
when compared to wild-type S. flexneri (Zurawski et al., 2008).
OspZ therefore plays a role in the migration of PMN leukocytes
across the epithelial barrier. However, Newton et al. (2010)
discovered that S. flexneri species, excluding S. flexneri serotype
6, contain a stop codon at amino acid 188, forming a truncated
protein lacking an IDSYMKmotif at position 209. The full length
OspZ proteins in the remaining Shigella species were found
to have an immunosuppressive function through prevention of
NFκB activation. Finally, an OspZ homolog, NleE, is found in
enteropathogenic Escherichia coli (EPEC), and both NleE and
OspZ can substitute for each other (Zurawski et al., 2008).
Serine Protease Autotransporters of
Enterobacteriaceae
Serine Protease Autotransporters of Enterobacteriaceae
(SPATEs) are a family of proteases which catalyse their
own secretion via the Type V secretion pathway. Shigella has
three known SPATEs, not all of which are found in each species.
Their secretion is thermoregulated (37◦C) and pH-dependent
(Dautin, 2010). They have different proposed activities relevant
to intestinal penetration: induction of mucin secretion and
cleavage (Pic), destabilization of focal adhesions via cleavage of
fodrin (SigA), and, through unknown targets, enterotoxicity,
fluid accumulation and epithelial desquamation (SigA and SepA)
(Table 3).
Shigella Enterotoxin 1 and Shigella Enterotoxin 2:
Enterotoxic Activity in the Jejunum
Shigella enterotoxin 1 (ShET1) and Shigella enterotoxin 2
(ShET2) are virulence determinants proposed to mediate early
fluid secretion in the jejunum to establish infection in the colon
and produce to the characteristic watery diarrhea seen early in
shigellosis. The shared name is due to their similar properties
as enterotoxins, as there is no homology between ShET1 and
ShET2.
ShET1 is encoded by set1A and set1B genes on the Shigella
chromosome as part of the SHI-1 PAI, and only present in
S. flexneri 2a isolates (Vargas et al., 1999) (Yavzori et al.,
2002). The two subunits are proposed to form a holo-AB-
type toxin complex in an A1-B5 configuration, producing a
55 kDa complex (Fasano et al., 1995). The holotoxin may
follow a secretion mechanism similar to that of the cholera
holotoxin, via the Sec pathway and Type II secretion. When
ion transport across a cultured epithelium was measured in an
Using chamber, a set1AB− knockout had 60% lower Isc (short
circuit current) in comparison to wild-type strains (Faherty et al.,
2012b). The effect on Isc of ShET1 was also dose-dependent,
and washout of ShET1 produced no change in Isc, indicating
irreversible binding of ShET1 to epithelial receptors (Fasano
et al., 1997). However, the set1A and set1B genes overlap with
the pic gene but are divergently transcribed. Therefore, the
additional pic− knockout may have caused these effects. Faherty
et al. (2012b) complemented the pic/set1AB mutant with pic
and set1AB individually, showing that pic has a more significant
contribution to restoring Isc levels to wild-type, although set1AB
complementation also produced a significant increase in Isc.
ShET2 is a 63 kDa protein encoded by ospD3 (sen). It
is found in all serotypes and one of the three ospD genes
found on the virulence plasmid. Sequence alignments between
ospD2 and ospD3 show a high degree homology while ospD1
is more divergent. OspD1 has a unique role in regulating
type III secretion not shared with OspD2 and OspD3 (Parsot
et al., 2005), but redundancy in their effector function(s) is
unknown. Unlike ShET1, ShET2 secretion is dependent on the
T3SS (Farfán et al., 2011) but how this is regulated unclear
(Faherty et al., 2016). The ospD3− (ShET2) knockout has similar
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TABLE 3 | SPATEs harbored by Shigella and their function in infection.
SPATE Gene location Putative function Role in infection References
Pic SHI-1 (opposite set1AB) Cleavage of mucin Penetrate colonic mucus layer to access epithelium Gutierrez-Jimenez et al., 2008
Mucin secretagogue Mucus-containing dysentery in shigellosis Navarro-Garcia et al., 2010
SigA SHI-1 Cytopathic activity Cleavage of fodrin to destabilize links between actin cytoskeleton
and membrane proteins, detachment of focal adhesions
Canizalez-Roman and
Navarro-García, 2003; Al-Hasani
et al., 2009
Enterotoxic activity Fluid accumulation Al-Hasani et al., 2000
SepA Virulence plasmid Enterotoxic activity Fluid accumulation Benjelloun-Touimi et al., 1995
Epithelial desquamation Disease progression Coron et al., 2009
effects in Using chamber experiments to a set1AB− (ShET1)
knockout, with reduced Isc increase in comparison to the wild-
type strain (Nataro et al., 1995). An ospD3− mutant also had
a reduction in IL-8 secretion, which could be restored to wild-
type levels by ospD3 plasmid complementation, indicating a
possible role in IL-8 secretion by epithelial cells (Farfán et al.,
2011).
Adhesion to the Colonic Epithelium at the
Basolateral Surface
Lipopolysaccharide: Glucosylation for T3SS
Accessibility
The lipopolysaccharide (LPS) is a common feature of Gram
negative pathogens, triggering the host immune response and
inflammatory reactions during infection. LPS modification by
glucosylation is thought to contribute to Shigella adhesion and
invasion by revealing the T3SS for efficient activation upon
contact with the host cell. Guan et al. (1999) showed that
glycosyltransferase gtrA− and gtrB− mutants had only a partial
conversion of the O-antigen serotype, and a gtrX− mutant had
no conversion at all. A mutation in the gtr operon leads to a
reduced ability to invade, and this invasion is restored when the
gtr operon is reintroduced (West et al., 2005). The reduction
in O-antigen length by glucosylation enhances accessibility of
the T3SS for contact with the host epithelial cell to initiate
invasion.
IpaB: Binds CD44 at the Basolateral Surface
IpaB mediates adhesion to the basolateral membrane via
interactions with the ubiquitous glycoprotein CD44 (Figure 1,
step 7). CD44 is located within lipid microdomain rafts, and
is involved in binding of ezrin, radixin, and moesin (ERM)
proteins to produce rearrangements of the actin cytoskeleton.
IpaB binds the CD44 N-terminal domain with weak affinity
but up-regulation of CD44 expression to levels found on
lipid microdomains increases binding and internalization of
Shigella (Skoudy et al., 2000). Lipid microdomain rafts are
found at the basolateral surface and the IpaB-CD44 adhesion
interaction may contribute to the polarity of Shigella invasion
of epithelial cells (Lafont et al., 2002). Although increased
adherence mediated by IpaB-CD44 binding may improve
invasion efficiency, this binding alone is not sufficient to
induce Shigella entry, as both ipaC− and ipaD− (see below)
mutants are unable to mediate invasion (Skoudy et al.,
2000).
IcsA (VirG): Polar Adhesion
IcsA, also referred to as VirG, is a 120 kDa outer membrane
protein. IcsA is not dependent on the T3SS for its secretion
as it is an autotransporter, with an atypical N-terminal signal
sequence mediating secretion via the Sec pathway (Brandon
et al., 2003). It is most well-known for its involvement actin
based motility, however a more recent function has been
described, whereby IcsA is involved in polar adhesion of
Shigella to epithelial cells (Brotcke Zumsteg et al., 2014). The
adhesion function can be separated from actin-based motility,
as an icsA− mutant complemented with a plasmid encoding
an adhesion-defective icsA formed plaques similar to wild-
type Shigella (Brotcke Zumsteg et al., 2014). The adhesion-
defective icsA also produced an attenuated infection phenotype
in the Sereny test, indicating the importance of IcsA as
an adhesin in Shigella pathogenesis. IcsA-mediated adhesion
was present in an ipaBCDA−mxiE− mutant, but not in an
ipaD−spa33− strain, indicating that the assembled T3SS, but
not the secretion of T3SS effectors, is required for adhesion
activity. This initial observation was then linked to T3SS-
dependent activation of IcsA to mediate this adhesive phenotype,
as the application of the bile salt deoxycholate (DOC) led
to an increase in IcsA-dependent adhesion (Brotcke Zumsteg
et al., 2014). Deoxycholate has previously been described
to bind to IpaD at the T3SS needle tip and induce IpaB
recruitment for T3SS activation (Barta et al., 2012). However,
DOC is also known to effect LPS molecules, causing them
to disperse within the membrane (Shands and Chun, 1980).
Assessment of protease accessibility using proteinase K with
an ipaD− mutant and after DOC treatment showed that
hyperadhesive IcsA was more resistant to degradation, and this
was proposed to be due to an alternate conformation of IcsA
induced by T3SS activation (Figures 4C, 5D—Brotcke Zumsteg
et al., 2014). However, as DOC does not activate the T3SS,
the changes in proteolysis banding are more likely due to
disruption of the LPS leading to altered accessibility of IcsA
producing different cleavage patterns. Changes seen in the ipaD−
mutant could occur via an independent regulatory pathway,
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whereby activation of the T3SS leads to modulation of LPS
structure.
OpsE1/E2: Bile Salts-Dependent Adhesion
Faherty et al. (2012a) also noticed that subculture in media
containing bile salts significantly enhanced ability of Shigella
to adhere to the apical surface of polarized epithelial cells.
However, microarray expression analysis indicated that the
ospE1/ospE2 genes were induced in the presence of bile, and
bile-induced adherence was lost in a 1ospE1/1ospE2 mutant.
The OspE1/OspE2 proteins, which are effectors secreted by the
T3SS, were also shown to remain localized to the bacterial outer
membrane following exposure to bile salts, where they may
therefore serve as adhesins.
Macropinocytic Uptake into Colonic
Epithelial Cell
IpaD and IpaB: Activation of the T3SS
IpaD is part of the Ipa family required for Shigella invasion, and
polymerizes at the T3SS needle tip (Espina et al., 2006). The
identification of Class I ipaD− mutants, which had premature
secretion of effectors, and Class II ipaD− mutants, which were
non-inducible, shows that IpaD has a dual role in the activation
of the T3SS (Roehrich-Doenitz et al., 2013). IpaD acts as the
scaffold protein at the tip of the T3SS needle acting as the
display support for IpaB, located at the needle tip along with
IpaD (Veenendaal et al., 2007), and the delivery mechanism
of the hydrophobic IpaB-IpaC translocation pore (translocon)
to host cell membranes (Blocker et al., 1999). From there
IpaD acts as a signal transducer to activate effector secretion
(Figure 4) (Roehrich-Doenitz et al., 2013). IpaD, in conjunction
with MxiC, is also part of the cytoplasmic signal transduction
pathway required for full activation of the T3SS and secretion of
remaining T3SS effectors (Martinez-Argudo and Blocker, 2010).
IpaB initially senses the host cell membrane in a manner that
is not yet understood and, with IpaD, co-transduces this signal
down the T3SS needle to activate secretion (Murillo et al., 2016).
IpaC: Actin Polymerization and Induction of Effector
Translocation
IpaC belongs to the group of Ipa proteins crucial for translocon
formation and cell invasion. The structure of IpaC includes
an N-terminal signal sequence, a region for association with
IpgC (cytoplasmic chaperone), a central hydrophobic region
for penetration of membranes, and a C-terminal domain for
oligomerization (Terry et al., 2008). The hydrophobic region
allows IpaC to interact with IpaB and insert into hostmembranes,
however its topology in the membrane is disputed. The use
of anti-IpaC monoclonal antibodies has shown that both the
N- and C-terminal regions face the host cell cytoplasm (Tran
Van Nhieu et al., 1999) although other experiments have found
that the central loop is on the cytoplasmic face, with the
N- and C-terminal regions being extracellular (Kuwae et al.,
2001). IpaC insertion into the epithelial cell membrane triggers
cytoskeletal rearrangements for the macropinocytic uptake of
Shigella (Figure 4). Menard et al. (1996) describe how an IpaB-
IpaC complex on the surface of latex beads is sufficient for
engulfment by non-phagocytic cells. However, this has not been
reproduced and therefore may not applicable in vivo. It is likely
that the IpaC C-terminus faces the host cytoplasm because IpaC
has been attributed the ability to polymerize actin indirectly at
its C-terminus, via interactions with Cdc42 and Rac GTPases
(Tran Van Nhieu et al., 1999) and activation of Src tyrosine
kinase pathway (Mounier et al., 2009). However, the Salmonella
homolog, SipC, can polymerize actin at its C-terminal domain,
independently of any host cell factor (Hayward and Koronakis,
1999). IpaC displays sequence similarity to SipC within its C-
terminal actin nucleation domain, and both IpaC and SipC use
this domain to oligomerize. IpaC may therefore also be capable
of polymerizing actin independently. In pull down assays, the
C-terminal domain of IpaC was incapable of binding to Cdc42
and Rac1, indicating that actin polymerization does not occur
through direct interactions with these GTPases (Terry et al.,
2008). Finally, the C-terminus of IpaC has also been shown to
bind vimentin and the intestinal epithelial intermediate filament
keratin 18. This interaction is required for stable docking of the
bacteria to cells and a prerequisite for induction of secretion of
the other effectors (Russo et al., 2016).
IpgB1 and IpgB2: Actin Remodeling
IpgB1 and IpgB2 share 25% amino acid identity and both
require Spa15 as a chaperone for secretion, with an additional
requirement for stability by IpgB1 (Hachani et al., 2007). They
contain a WxxxE motif which is common in guanine nucleotide
exchange factors (GEFs) involved in the activation of Rho
GTPases. These GTPases are required for the induction of actin
filament structures to produce membrane ruﬄes for bacterial
entry into non-phagocytic cells. An ipgB1− knockout has a
50% reduction in epithelial cell invasion compared to the wild
type stain, which was restored when complemented by plasmid-
expression of ipgB1 (Ohya et al., 2005). Membrane ruﬄe size
is also affected, as wild-type strains achieved ruﬄe size of
60µm2, an ipgB1− mutant achieved 16µm2, and an ipgB1-
hyperproducing strain achieved 138µm2 (Ohya et al., 2005). This
indicates that IpgB1 is involved in the production of membrane
ruﬄes in a dose-dependent manner. It was disputed as to whether
IpgB1 activated Rac1 directly (Alto et al., 2006) or whether
IpgB1 mimicked RhoG for activation of Rac1 indirectly via the
ELMO-Dock180 pathway (Handa et al., 2007). However, crystal
structures of IpgB1 confirmed that it acts as a GEF, specifically
recognizing the β2-3 residues of Cdc42 and Rac1 GTPases to
catalyse the GDP-GTP exchange for activation (Huang et al.,
2009). Crystal structures and functional studies also confirmed
that IpgB2 is a GEF capable of directly binding and activating
RhoA (Huang et al., 2009; Klink et al., 2010). Activation of
Rac1 and RhoA by IpgB1 and IpgB2 contributes to formation
of lamellipodia and actin stress fibers, respectively. In the Sereny
test, an ipgB2− mutant produced the same disease phenotype
as the wild-type strain, and a negative result only occurred in
an ipgB1−ipgB2− mutant, indicating redundancy (Hachani et al.,
2007). However, an ipgB1−mutant alone produced a more severe
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FIGURE 4 | Role of IpaD, IpaB, and IpaC in regulation of the T3SS (Martinez-Argudo and Blocker, 2010). Four hydrophilic IpaD molecules and one
hydrophobic IpaB molecule are localized at the tip of the T3SS needle in the “off” state. IpaB senses host cells upon contact of the T3SS needle tip, and inserts into
the membrane to signal “translocators on.” Secretion of effectors is signaled by conformational changes in IpaD via a signal transduction pathway to the base of the
secreton. Four IpaC may travel up the secreton and associate with the needle tip, one atop each IpaD, and insert around the single IpaB to form a translocon in the
epithelial cell membrane. This signals “effectors on” and early effectors are injected into the cytoplasm of the host epithelial cell (Veenendaal et al., 2007).
inflammatory phenotype than the wild-type strain, which was
unexpected.
IpaA: Actin Depolymerization
IpaA is involved in regulating actin protrusions at the epithelial
membrane and depolymerization of actin filaments in the host
cell during Shigella entry. This is postulated to be achieved
through its interactions with vinculin, a host protein that links
the cytoskeleton to the extracellular matrix and is involved
in focal adhesion structures. There are three vinculin binding
sites, which are arranged tandemly at the IpaA C-terminus,
each of which can bind one vinculin head. Binding of IpaA to
the vinculin head induces a conformational change in vinculin,
revealing an F-actin binding site in the vinculin tail (Izard
et al., 2006). IpaA is important for cell entry, as an ipaA−
mutant has a 10-fold decrease in invasion capacity, and requires
vinculin to mediate its effects, as vinculin-deficient cells had a
similar invasion defect (Tran Van Nhieu et al., 1997). Pelleting
assays showed that no actin depolymerization occurred in the
presence of IpaA or vinculin alone, with actin principally in
the pellet, but when the IpaA:vinculin complex was added,
actin was found mostly in the supernatant, with the amount
of depolymerization correlating with vinculin concentration
(Bourdet-Sicard et al., 1999). The IpaA:vinculin complex has
a 3-fold increased affinity for F-actin compared to vinculin
alone and acts as a “leaky cap” on the barbed end of the F-
actin filaments to prevent addition of further monomers and
cause depolymerization (Bourdet-Sicard et al., 1999; Ramarao
et al., 2007). IpaA therefore prevents the uncontrolled formation
of IpaC-induced microspike structures at the site of bacterial
contact, which would repel Shigella from the epithelial cell surface
(Tran Van Nhieu et al., 1997).
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IpgD: Membrane Ruffles
IpgD plays an important role in the formation of bacterial
entry structures on contact with host epithelial cells. An ipgD−
mutant induces a less efficient entry structure than the wild
type, due to smaller membrane ruﬄes and a reduction in actin
rearrangements (Niebuhr et al., 2000). IpgD functions as an
inositol (phosphoinositide) 4-phosphatase, and has sequence
motifs similar to mammalian phosphoinositide phosphatases
and Salmonella homolog SopB/SigD with similar inositol
phosphate phosphatase activity (Niebuhr et al., 2002). Its main
substrate in the host cell is phosphatidylinositol 4,5-bisphosphate
[PtdIns(4,5)P2/PIP2] which it desphosphorylates to produce
phosphatidylinositol 5-monophosphate [PtdIns(5)P/PI5P]. An
ipgD− mutant, or IpgD with a cysteine to serine (C438S)
substitution in its active site, has no affect on PtdIns(4,5)P2
levels (Niebuhr et al., 2002). The dephosphorylation activity of
IpgD on PtdIns(4,5)P2 correlates with a decrease in membrane
tether force, as PtdIns(4,5)P2 controls the adhesion force
between the plasma membrane of the epithelial cell and the
actin cytoskeleton (Niebuhr et al., 2002). Combined with actin
cytoskeleton rearrangementsmediated by other Shigella effectors,
the reduction in membrane tether allows the extension of
filopodia and membrane ruﬄes characteristic of the trigger
mechanism seen in Shigella entry into non-phagocytic cells
(Figure 1, step 7) (Niebuhr et al., 2002). IpgD inositol-4
phosphatase activity has also been implicated in a positive
feedback loop involving ARF6 GTPase (Garza-Mayers et al.,
2015), which stimulates actin remodeling and membrane ruﬄes
through Rac1 activation. The production of PtdIns(5)P by IpgD
activates phosphoinositide 3-kinase (PI3K), which generates
PtdIns(3,4,5)P3. This recruits ARF nucleotide binding site
opener (ARNO), a GEF that activates ARF6 GTPase. Active
ARF6-GTP promotes actin remodeling through Rac1-dependent
pathways, further contributing to membrane ruﬄes for Shigella
entry.
Replication and Spread within Colonic
Epithelium
IpaB and IpaC: Lysis of Single Membrane Entry
Vacuole?
Due to the pre-requisite for invasion of epithelial cells and
time coupling between entry and vacuolar lysis (15 min),
disruption of components required for entry can seem to
have pleotrophic effects on downstream infection events. This
creates intrinsic limitations in studying their role in intracellular
pathogenesis (Guichon et al., 2001). Nonetheless, an “entry
region” encoding only the T3SS and IpaD, IpaB, and IpaC has
been demonstrated to be sufficient for vacuolar lysis (Figure 1,
step 8) (Sansonetti et al., 1986; Du et al., 2016). High et al.
(1992) used macrophages, which are naturally phagocytic, to
overcome the non-invasive ipaB− phenotype, and described
how IpaB plays a role in lysis of the phagocytic vacuole.
It has been postulated that the insertion of the IpaB-IpaC
translocon into the vacuolar membrane is the cause of membrane
lysis (High et al., 1992). This would occur through pore
formation, which could lead to vacuolar destabilization, or
through translocation of unidentified membranolytic effector(s)
across the membrane (Page et al., 1999). Senerovic et al. (2012)
found that purified IpaB internalized into cells oligomerized in
endocytic membranes to form ion channels which affected their
integrity. However, the IpaB used was purified recombinantly
using a detergent, which naturally lyses membranes, and
this effect was not controlled for. Moreover, when within
the naturally inserted translocon IpaB is connected to the
T3SS via the needle tip, which - along with low osmolarity
in the vacuole - would prevent the influx of water into
the vacuole to cause lysis. Furthermore, by exploring the
functional interchangeability of translocon components from
Shigella and Salmonella, which remains in its invasion vacuole,
IpaC was shown to be directly involved in lysis of the single
membrane vacuole (Osiecki et al., 2001; Du et al., 2016). Yet,
any environmental cue for the translocon to switch between
possible invasion, translocation, and lysis conformations remains
unknown.
IpgD: Lysis of Single Membrane Entry Vacuole?
IpgD may be involved in the modulation of the Shigella-induced
entry vacuole by recruiting Rab11 to macropinosomes. An
siRNA screen and Rab11-depleted cells showed that the absence
of Rab11, a small GTPase involved in endocytic recycling,
leads to decelerated Shigella-induced vacuolar rupture. Like
the Rab11-depleted cells, vacuolar rupture was delayed in an
ipgD− mutant, taking twice as long as for the wild-type strain
(Mellouk et al., 2014). Functionally impaired Rab11 and a
GDP-locked dominant negative Rab11 showed that it is the
absence of Rab11 activity that causes this delay in vacuolar
rupture (Weiner et al., 2016). Immunofluorescence staining co-
localized Rab11-positive vesicles at the Shigella invasion site
and Shigella-containing vacuoles, however this accumulation did
not occur if an ipgD− mutant or IpgD lacking its inositol-4
phosphatase activity was present in the vacuole (Mellouk et al.,
2014). Using C-FIB/SET, Weiner et al. (2016) then showed
that the Rab11-positive vesicles are macropinosomes, which are
formed during membrane ruﬄing induced by Shigella. IpgD is
involved in macropinosome formation, through its stimulation
of ruﬄing, and hence in making these organelles available to
the Shigella entry vacuole (Weiner et al., 2016). Macropinosomes
are required for efficient entry vacuole rupture and have been
visualized close to the entry vacuole, making direct contact
just prior to vacuolar rupture (Weiner et al., 2016). This
suggests that the phosphoinositide phosphatase activity of IpgD
is required to regulate Rab11 recruitment to macropinosomes for
attachment to the Shigella-containing entry vacuole (Figure 6).
How macropinosome attachment, which does not lead to
fusion with the vacuole, leads to rapid vacuolar rupture is
unknown.
IcsA (VirG): Actin-Based Motility
IcsA is an autotransporter and is composed of three domains:
An N-terminal signal sequence, a C-terminal β barrel core which
forms a pore in the outer membrane, and a central α-domain
which is translocated through the β core membrane pore and
present at the Shigella surface (Suzuki et al., 1995). Surface
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exposed IcsA is sometimes cleaved, however this is not required
for IcsA function (Fukuda et al., 1995). The importance of IcsA
in Shigella intercellular spread was identified early, as an icsA−
mutant was unable to spread within an epithelial monolayer (as
measured by plaque formation) and had a negative Sereny test
(Bernardini et al., 1989). IcsA-mediated actin based motility is
sufficient for membrane protrusion formation (Figure 1, step 10)
and entry into neighboring cells (Figure 5). IcsA acts as a mimic
of Cdc42 to activate N-WASP, which allows the N-WASP C-
terminus to recruit Arp2/3 (Egile et al., 1999; Shibata et al., 2002).
This promotes rapid F-actin assembly and filament growth at the
N-terminus of N-WASP, providing a propulsive force for Shigella
to move through the cell. When icsA is expressed in E. coli,
these bacteria are capable of formingmembrane protrusions with
similar morphology to Shigella-induced protrusions, indicating
that no other Shigella factors are required for this process
(Monack and Theriot, 2001). Shigella factors, such as IcsP (SopA),
are required for correct localization and cleavage of IcsA at the
Shigella surface, contributing to efficient motility (Egile et al.,
1999). On addition of icsP to icsA-expressing E. coli there was
an increase in actin polymerization and increase protrusion
frequency. Furthermore, in E. coli LPS O-antigen mutants there
was a decrease in formation of actin tails compared to the
wild-type. A galU− mutant, which normally encodes a UDP-
glucose pyrophosphorylase involved in O-antigen biosynthesis,
produces a diffuse circumferential pattern of IcsA on the Shigella
surface, which is still capable of polymerizing actin but forms
no membrane protrusions (Sandlin et al., 1995). However, it is
unknown how the LPS modulates IcsA localization. Therefore,
both IcsP and LPS are required for the unipolar localization
of IcsA to produce efficient unidirectional movement, which
is strongly correlated with frequency of membrane protrusions
(Monack and Theriot, 2001).
IcsB: Inhibition of Autophagy
IcsB requires the IpgA chaperone for both its stability and
its secretion (Ogawa et al., 2003). An icsB− mutant produced
plaques with a smaller diameter than the wild type and a negative
result in the Sereny test, suggesting a role for IcsB post-invasion.
This role is the prevention of autophagy (Figure 5). IcsB prevents
autophagic recognition bymasking the Atg5 binding site on IcsA,
preventing Atg5 from binding and initiating autophagosome
formation. IcsB is also capable of recruiting Toca-I to prevent
LC3-mediated phagocytosis (Baxt and Goldberg, 2014). IcsB
prevents the formation of septin cages, which in turnmay prevent
the recruitment of ubiquitin (Ub), p62 and NDP52 (Huang
and Brumell, 2014). In an icsB− knockout, autophagic double
membranes were visualized around the Shigella bacilli, with
asymmetric distribution similar to IcsA placement (Ogawa et al.,
2005). IcsB, in conjunction with VirA, has also been implicated
in lysis of the double membrane entry vacuole after intercellular
spread (Figure 1, step 11). Electron microscopy (EM) 3 h after
cell infection visualized icsB− mutants remaining trapped in a
double membrane, with several bacteria in one vacuole (Allaoui
et al., 1992). Galectin-3 had then been used to show that an
icsB− mutant has only a 53% disruption of the double membrane
vacuole, compared to 70% disruption mediated by the wild type
FIGURE 5 | IcsA mediates actin-based motility and IcsB prevents
autophagy. IcsA is localized in a unipolar fashion to promote efficient
unidirectional intracellular movement parallel to the long axis of Shigella for
movement intra- and intercellularly. IcsB masks the Atg5 recognition site on
IcsA, recruits Toca-I, and prevents the formation of septin cages.
(Campbell-Valois et al., 2015). However, on closer inspection,
we think the EM images (Allaoui et al., 1992, Figure 8B) were
misinterpreted, and the double membrane interpreted as the
secondary entry vacuole was actually a starting autophagosome
wrapping around the icsB− mutant unable to inhibit autophagy.
Furthermore, galectin-3 can be used to label endomembranes
or autophagic membranes, as it interacts with β-galactose-
containing glycoconjugates which are present in both endocytic
and secretory compartments (Maejima et al., 2013). Therefore,
instead of rupturing the secondary entry vacuole IcsB inhibits
autophagy of Shigella.
VirA: Inhibition of Autophagy and Promotion of Golgi
Fragmentation
VirA was initially thought to play a role in Shigella invasion,
as a virA− mutant had a 5-fold reduced capacity for invasion
(Uchiya et al., 1995). This was linked to its apparent cysteine
protease activity and capability for microtubule degradation
(Yoshida et al., 2002). However, structural analysis showed that
VirA lacks the suggested papain-like protease activity for tubulin
cleavage, and instead exhibits homology with EspG, an EPEC
effector that fragments the Golgi (Germane et al., 2008). VirA
belongs to a family of GTPase-Activating Proteins, which share
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the conserved Rab GTPase catalytic Tre-2/Bub2/Cdc16 domain
to mediate Rab1 GTP hydrolysis (Dong et al., 2012). Rab1
GTPase is involved in ER-to-Golgi vesicular transport and is
crucial in the formation of autophagosomes (Zoppino et al.,
2010). VirA stabilizes Rab1 in the inactive GDP state, thereby
directly interfering with autophagy induction and ER-to-Golgi
trafficking (Figure 6) (Dong et al., 2012; Huang and Brumell,
2014). A virA− mutant leads to reduced Shigella intercellular
persistence, but does not greatly reduce Golgi fragmentation,
as IpaJ is more potent in fragmenting the Golgi (Figure 6)
(Dong et al., 2012; Burnaevskiy et al., 2013). VirA, similarly to
IcsB, has been implicated in the disruption of the secondary
vacuole after intercellular spread followingmembrane protrusion
formation (Figure 1, step 10) (Campbell-Valois et al., 2015).
However, like for IcsB, this may have been misinterpreted. In
FIGURE 6 | VirA and IpaJ mediate Golgi fragmentation, which may
contribute to entry vacuole disruption. There is a level of semi-redundancy
between VirA and IpaJ, as a double virA− ipaJ− knockout is required to
completely abolish Shigella-induced Golgi fragmentation. IpaJ is the dominant
effector, and targets ARF1-GTP for N-myristoylated cleavage at the exposed
di-glycine motif. ARF1 is irreversibly lost from the Golgi membrane, leading to
inhibition of Golgi trafficking (Burnaevskiy et al., 2013). VirA is capable of
interacting and inactivating many Rab GTPases to mediate Golgi
fragmentation, including Rab1 at the ER and Rab33 at the Golgi (Dong et al.,
2012). This causes disruption of ER-to-Golgi trafficking, leading to
fragmentation of the Golgi. Inactivation of Rab35 at the recycling endosome
may prevent recruitment of additional membrane to the Shigella entry vacuole.
Replication of Shigella within the entry vacuole without additional membrane
may then allow vacuole lysis. IpgD may also contribute to vacuole lysis by
recruiting Rab11 to macropinosomes, which have been shown make contact
with the entry vacuole to accelerate vacuolar rupture (Mellouk et al., 2014;
Weiner et al., 2016).
our view, the evidence indicates that VirA is involved in lysis
of the single membrane entry vacuole (Figure 1, step 8). Indeed,
Lysosomal Associated Membrane Protein 2 (LAMP2), a marker
for lysosomal fusion with the entry vacuole, has been localized
by confocal microscopy to entry vacuoles containing a single
virA−mutant and a double icsB−virA−mutant (Campbell-Valois
et al., 2015, Figures 2B, 3C) (Dong et al., 2012, Figure S3). A
single icsB− mutant is capable of escaping the entry vacuole,
visualized by actin comet tail formation (Allaoui et al., 1992,
Figure 8A). Therefore, the lack of escape from a single membrane
entry vacuole by the double icsB−virA− mutant (Campbell-
Valois et al., 2015, Figure 4) can be attributed to loss of
VirA function. To confirm this, EM analysis of a single virA−
mutant is required. VirA may mediate vacuolar lysis through
an indirect mechanism, whereby its inhibition of endosomal
trafficking prevents membrane vesicle fusion to the entry vacuole
(Figure 6). This could occur through interactions with multiple
Rab GTPases, as in vitro assays have indicated that VirA can
bind many Rab proteins involved in ER-to-Golgi traffic and
recycling (Dong et al., 2012). The vacuole may consequently lyse
as it cannot grow to accommodate Shigella replication. Passive
lysis of the vacuole has been shown for Salmonella, whereby a
sifA− knockout prevents the recruitment of membrane to the
entry vacuole. The vacuole cannot sustain Salmonella replication
and subsequently lyses, releasing Salmonella into the epithelial
cytoplasm (Beuzón et al., 2000).
IpaJ: Golgi Fragmentation
ipaJ is encoded downstream of the ipaBCDA operon and
transcribed divergently to it. But the original ipaJ− mutant
showed no defect in plaque formation and was Sereny test
positive. Therefore, it did not seem to play a crucial role
in epithelial invasion or cell-to-cell spread (Buysse et al.,
1997). Structural bioinformatics analysis indicated that IpaJ
harbored catalytic residues required for peptide bond hydrolysis,
and further experiments identified that IpaJ is a cysteine
protease which preferentially cleaves N-myristoylated proteins
(Burnaevskiy et al., 2013). Although in vitro studies indicated that
IpaJ has a large spectrum ofN-myristoylated targets (Burnaevskiy
et al., 2015, Figure 1D), in vivo it specifically targets ADP-
ribosylation factors (ARF), particularly ARF1 (Burnaevskiy et al.,
2015, Figure 4D). ARF1 GTPase is localized to the Golgi
membrane and the plasma membrane as it plays a role in ER-to
Golgi transport, including vesicle formation for cargo transport
and maintenance of the Golgi (D’Souza-Schorey and Chavrier,
2006). Removal of the myristoyl group from GTP-active ARF1
by IpaJ causes its irreversible release from the Golgi, inhibiting
vesicular trafficking (Figure 6). An ipaJ− mutant has no effect on
the ARF1 intracellular pool, but the wild-type strain decreases
the amount of ARF1 GTPase bound to the Golgi (Burnaevskiy
et al., 2015). Mounier et al. (2012) suggested that IpaB mediates
Golgi fragmentation via modulation of themembrane cholesterol
concentration, and state that VirA has no obvious effect on
disruption. However, the effects of IpaJ were not accounted for,
and as the dominant effector in this semi-redundant pair, it
is likely that effects attributed to IpaB were actually mediated
by IpaJ. The consequences of Golgi disruption by IpaJ are not
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fully understood but inhibition of STING relocalization from the
endoplasmic reticulum (ER) to the intermediate compartment
between ER and Golgi (ERGIC) may be one them (Dobbs
et al., 2015). STING is a major sensor of cytoplasmic pathogens
through detection of DNA and cyclic dinucleotides, where upon
it translocates from the ER to ERGIC and activates of the IFN-I
pathway.
OspE1 and OspE2: Promotion of Host Cell Adherence
to Basement Membrane
OspE1 and OspE2 are 99% identical, which suggests they may
have arisen from a gene duplication event (Buchrieser et al.,
2000). They are capable of functioning redundantly, however
in S. sonnei, ospE1 is a pseudogene (Miura et al., 2006). An
ospE2− knockout caused cellular rounding that was not as a result
of apoptosis or necrosis, and wild-type phenotype was restored
when ospE2 knockouts were complemented with functioning
ospE2 encoded on a plasmid (Miura et al., 2006). OspEs are
capable of interacting with integrin-linked kinase (ILK), which
is found in the membrane of host cells where it reinforces focal
adhesions (Kim et al., 2009). The interaction between OspE and
ILK reinforces adhesion contacts between the epithelial cell and
the basement membrane (Miura et al., 2006). The OspE-ILK
complex interferes with focal adhesion disassembly, reducing
focal adhesion kinase phosphorylation and increasing surface β1
integrins (Kim et al., 2009). Tagged OspE was visualized at focal
adhesions, however it was diffuse in ILK−/− cells, indicating that
ILK is required for OspE membrane localization, and this in
turn increases the amount of ILK in the host membrane (Miura
et al., 2006). An in vivo inoculation model in the distal colon of
guinea pigs showed no Shigella-induced symptoms when a dual
ospE knockout was used, however dual complementation of ospE
restored the wild-type phenotype, with both inflammation and
hemorrhaging (Kim et al., 2009).
IpaB: Cell Cycle Arrest
IpaB has been linked to cell cycle arrest through interactions
with Mad2L2, an anaphase promoting complex inhibitor (Iwai
et al., 2007). Mad2L2 is involved in promoting entry of epithelial
cells into mitosis during G2/M phase by interacting with the
Cdh1, an anaphase promoting complex (APC) associated factor
involved in preventing mitosis. After mitosis has occurred,
Mad2L2 and Cdh1 dissociate and Cdh1 is activated to suppress
mitotic cyclins. IpaB interferes with Mad2L2-Cdh1 binding,
causing Cdh1 to be constitutively activated (Iwai et al.,
2007). Permanent mitotic cyclin suppression by Cdh1 prevents
epithelial turnover during Shigella infection, promoting more
efficient bacterial replication by keeping the cells better attached
to the adjacent cells and to the lamina. Cell cycle arrest
thereby prevents epithelial cell turnover and allows Shigella
to establish a better niche for replication. Interactions with
Mad2L2 allow IpaB to be translocated into the epithelial nucleus
(Iwai et al., 2007). IpaB binds Mad2L2, and this occurs at
the same location on IpaB where the IpgC chaperone binds.
Introduction of a single amino acid substitution conferring
weaker binding of IpaB to Mad2L2 leads to a reduction in
colonization of rabbit ileal loops suggesting that IpaB and its
interaction with Mad2L2 contributes to more efficient Shigella
colonization of the epithelium (Iwai et al., 2007, Figure 6B).
However, the point mutation could instead have pleotropic
effects on IpaB function (see IpaB and IpaC: Lysis of single
membrane entry vacuole?) rather than directly affecting Mad2L2
binding.
Lysis of the Double Membrane Vacuole
Vps and VacJ: Proposed ABC Transporter
The vpsABC operon is found on the Shigella chromosome,
and consists of VpsA, a possible ATP-Binding Cassette
(ABC) transporter protein, and VspB and VspC, proposed
transmembrane proteins. Both vpsC− and vspA− knockouts
had a defect in plaque formation but were similar to wild-
type strains in their capability to invade, indicating that they
play a role in intercellular spread (Hong et al., 1998). VacJ
is also encoded on the chromosome, and a vacJ− knockout
is incapable of escaping into the recipient cell cytoplasm,
suggesting that VacJ also plays a role in intercellular spread
(Suzuki et al., 1994). Carpenter et al. (2014) describe a
Vps/VacJ ABC transporter, which maintains asymmetry of
lipids in the outer membrane and in the context of Shigella
infection is required for lysis of the double membrane vacuole.
Transformation of vps/vacJ knockouts with a plasmid expressing
pldA, a phospholipase in other Gram negative bacteria, was
able to restore the maintenance of outer membrane lipid
asymmetry but was unable to lyse the double membrane
vacuole, indicating that these two functions of the proposed
Vps/VacJ ABC transporter are separate (Carpenter et al., 2014).
Another substrate may therefore be transported across the
membrane to induce vacuolar lysis, however this is yet to be
discovered.
IpaB and IpaC: Translocon Formation and Lysis of
the Double Membrane Vacuole
Studying intracellular roles of IpaB and IpaC is difficult as their
non-invasive mutants have pleotropic effects. However, Page
et al. (1999) overcame this issue using a recombinant plasmid
with IPTG-inducible lac promoter to regulate expression of
IpaB and IpaC. After initial entry, IPTG was removed from the
medium, producing ipaB− and ipaC− phenotypes which have a
3-fold decrease in plaque diameter compared to the wild-type.
The inducible ipaB− or ipaC− mutants both exhibited a defect
in lysis of the double membrane vacuole (Figure 1, step 11), with
abolished membrane contact formation (Campbell-Valois et al.,
2014). Several bacteria were visualized within such vacuoles,
indicating that enough time was spent in the vacuole for
replication to occur (Page et al., 1999). IpaB is located at the
needle tip along with IpaD, from where it senses the host cell
membrane (Murillo et al., 2016). Therefore, its interactions with
the inner surface of the plasma membrane during membrane
protrusion formation may induce the on-off regulation of the
T3SS in the epithelial cell cytoplasm (Campbell-Valois et al.,
2014) and fresh translocon insertion and/or translocation of
unidentified effector(s) involved in lysis of the first or second
membrane of the double membrane vacuole.
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Modulation of Innate Immune System
We cover here effectors directly involved in suppressing the
innate immune response in epithelial cells and/or macrophages,
rather than events up-stream of it discussed above, such as
autophagy.
OspC3: Inhibits Caspase-4-Mediated Inflammatory
Cell Death
OspC3 is part of the ospC gene family. An ospC3− mutant has
an increased inflammatory cell death when compared to wild-
type Shigella and ospC1−/ospC2− mutants (Kobayashi et al.,
2013). This indicates that OspC3 plays a role in the down-
regulation of acute inflammatory cell death, and suggests a
lack of redundancy in the ospC family as OspC1 has pro-
inflammatory effects. Inflammatory cell death was not abolished
with a cytochrome c or caspase-3/caspase-7 inhibitor. However,
a caspase-1/caspase-4/caspase-5 inhibitor did reduce cytotoxicity
and their activity increased during ospC3− infection, suggesting
that OspC3mediates its activity via one of these caspase pathways
(Kobayashi et al., 2013). Tagged OspC3 bound to the caspase-
4 p19 subunit in a pull-down assay, and in-frame deletions
showed that the terminal 190–484 residues of OspC3 were
involved in p19 binding, specifically at a conserved consensus
sequence, X1-Y-X2-D-X3 (Kobayashi et al., 2013). Substitution
of all five residues with alanine, in addition to substitution
of the conserved 450–478 residues in the C-terminal ankyrin
region, impaired OspC3 binding to p19 and increased epithelial
cytotoxicity (Kobayashi et al., 2013). Incubation of the p19
subunit with increasing concentrations of OspC3 correlated
with increasingly impaired p19–p10 binding (Kobayashi et al.,
2013). The biochemical function of OspC3 may therefore be
interacting with p19 to inhibit caspase-4 activation and prevent
inflammatory cell death (Figure 7).
OspF: Inactivates MAPKs Which Prevents
Phosphorylation of Histone H3
OspF was first described as a dual specific phosphatase (Arbibe
et al., 2007), desphosphorylating threonine and tyrosine residues
in the MAPK signaling pathway (Figure 7). However, it was
determined by Li et al. (2007) through tandemmass spectrometry
that OspF instead displays phosphothreonine lyase activity in
that it irreversibly desphosphorylates threonine, but not tyrosine,
through beta elimination (Zhu et al., 2007). An ospF− mutant has
increased PMN recruitment and severity of epithelial destruction
in the rabbit ileal loop model when compared to the wild-type
strain, indicating a role in down-regulating the immune response
to Shigella infection (Arbibe et al., 2007). Phosphothreonine lyase
activity is also seen in SpvC, a Salmonella homolog with 63%
amino acid identity with OspF. Antibodies against phospho-
amino acids confirmed specific removal of phosphate from
FIGURE 7 | Shigella modulates the innate immune response in epithelial cells. NFκB can be activated via many pathways during Shigella infection, including
genotoxic stress during invasion and recognition of the lipopolysaccharide on the bacterial surface. This may explain the redundancy of Shigella effectors, many of
which have the ability to interfere with these pathways, leading to efficient inhibition of NFκB. IpgD increases levels of PI5P, which activates PI3K and Akt and inhibits
p53 and caspase 3. OspC3 sequesters the p19 pre-cursor of caspase 4, which prevents its heterodimerization with p10 and inhibits capase 4 activation. OspI
deamidates Ubc13, which inhibits ubiquitination of TRAF6 and prevents activation of the TRAF6-NFκB pathway. IpaH0722 ubiquitylates TRAF2, leading to its
proteasomal degradation and preventing recruitment of IKK and activation of NFκB. Polyubiquitination of NEMO/IKKγ is dependent on IpaH9.8 binding to A20 binding
inhibitor of NFκB (ABIN-1), leading to proteasomal degradation of NEMO/IKKγ, activation of IκBα, and inhibition of NFκB. IpaH9.8 also localizes to the nucleus where
it catalyses ubiquitination of U2AF35, leading to its degradation and consequently reduced il-8 expression and decreased neutrophil recruitment. By an unknown
mechanism, OspG prevents SCFβ−TrCP from ubiquitinating IκBα, preventing degradation of IκBα and activation of NFκB. OspZ blocks the nuclear translocation of
p65, a subunit of NFκB, thereby inhibiting activation of NFκB. Threonine desphosphorylation of MAPKs by OspF leads to inactivation of ERK1/2 and p38 MAPK
pathways and inhibition of histone H3 phosphorylation (H3pS10). This produces an inaccessible chromatin conformation at the gene promoters of inflammatory
cytokines and chemokines, meaning NFκB cannot activate their transcription.
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threonine which inactivates MAPKs (Mazurkiewicz et al., 2008).
OspF has also been attributed pro-inflammatory roles (Zurawski
et al., 2006; Reiterer et al., 2011). The identification of accurate
in vivo substrates may explain the apparent pro- and anti-
inflammatory roles mediated by OspF.
OspG: Inhibits NFκB Activation
OspG plays a role in dampening the host immune response,
shown by an ospG− mutant exhibiting increased inflammation
and destruction of the mucosa in comparison to wild-type
Shigella in the rabbit ileal loopmodel (Kim et al., 2005). OspG has
a minimal kinase domain, and its kinase activity requires binding
of an E2 ubiquitin conjugating enzyme in conjunction with
ubiquitin (Pruneda et al., 2014). Binding of UbcH7∼Ub stabilizes
OspG and confers an active kinase conformation, increasing
kinase activity 20-fold (Grishin et al., 2014). OspG is also capable
of binding UbcH5b∼Ub, which is a component of the E3 ligating
enzyme SCFβ−TrCP (Kim et al., 2005). An ospG− mutant exhibits
IκBα degradation 20 min post-invasion, whereas in wild-type
Shigella this degradation occurs after 60 min (Kim et al., 2005).
The exact mechanism of how OspG prevents SCFβ−TrCP from
ubiquitinating phospho-IκBα is unknown, but the OspG kinase
activity is postulated to be involved in the attenuation of NFκB
activation (Figure 7) (Zhou et al., 2013).
OspI: Inhibits NFκB Activation
OspI functions as a glutamine deamidase, and has been shown to
interfere with NFκB activation via the TNF-receptor-associated-
factor (TRAF) 6 pathway (Sanada et al., 2012). An ospI− mutant,
when compared to wild-type Shigella, leads to increased levels of
cytokine mRNA transcripts, increased phosphorylation of IκBα
and a 4-fold increase in nuclear translocation of the p65 subunit
of NFκB (Sanada et al., 2012). All of these lead to increased NFκB
activation and consequently an increase in the host inflammatory
response. OspI has a cysteine-histidine-aspartic acid catalytic
triad which is crucial for deamidation, as activity was abolished
by a cysteine-to-serine substitution (Sanada et al., 2012). A
substrate of OspI is UBC13, an E2 ubiquitin conjugating enzyme
required for TRAF6-induced NFκB activation, shown by binding
of OspI to His-UBC13 during pull-down assays (Nishide et al.,
2013). Hydrophobic interactions are important for this binding,
and a crystal structure shows a glutamine residue at position
100 on UBC13 is positioned in the OspI active site (Nishide
et al., 2013). OspI specifically deamidates Gln100, converting it
to glutamic acid and abolishing the E2 ubiquitin conjugating
function of UBC13 to prevent activation of the TRAF6-NFκB
pathway (Figure 7) (Sanada et al., 2012).
OspZ: Inhibits NFκB Activation
As previously described, OspZ has a pro-inflammatory role in
some S. flexneri species. In the remaining Shigella species the full
length OspZ has an anti-inflammatory role, similar to that of its
NleE homolog in EPEC (Newton et al., 2010). Both NleE and
OspZ have been shown to block the nuclear translocation of p65,
a subunit of NFκB, in response to TNFα and IL-1β (Figure 7).
This leads to a reduction in transcription of pro-inflammatory
cytokine genes, such as il-8, thereby reducing inflammation
during Shigella infection. OspZ and NleE are also capable of
inhibiting IκB degradation, further suppressing NFκB activity.
Newton et al. (2010) determined that the crucial region for the
anti-inflammatory effect of OspZ and NleE was between the
amino acids 208–214, and has the sequence IDSYMK. Deletion
of this region or single amino acid substitutions for alanine
in NleE led to an increase in NFκB-dependent transcription
(Newton et al., 2010, Figure 6D). NFκB activity was not abolished,
indicating that this region is a binding site rather than an
enzyme active site. The precise mechanism of how OspZ inhibits
IκB degradation is unknown. However, Nadler et al. (2010)
propose that NleE inhibits IKKβ, which is normally responsible
for IκB phosphorylation and degradation in response to pro-
inflammatory stimuli. OspZ may therefore work by a similar
mechanism to prevent NFκB activation.
IpaH9.8: Inhibits NFκB Response
IpaH9.8 is a member of the ipaH gene family, and one of
four found on the virulence plasmid, which includes ipaH1.4,
ipaH2.5, ipaH4.5, and ipaH9.8. IpaH proteins are characterized
by an N-terminal leucine-rich repeat (LRR) region and a highly
conserved C-terminal region (CTR) which contains a cysteine
residue (Suzuki et al., 2014a). The LRR motif is thought to play
a role in protein-protein interactions, such as cell adhesion and
signaling, while the cysteine residue in the CTR is required for
enzyme 3 (E3) ubiquitin ligase activity. An ipaH9.8− mutant has
an increased inflammatory phenotype in comparison to wild-
type Shigella in the murine lung model, indicating that IpaH9.8
has a role in attenuating inflammation during Shigella infection
(Okuda et al., 2005). This is achieved through E3 ubiquitin
ligase activity via the CTR of IpaH9.8 (Rohde et al., 2007). The
substrates of IpaH9.8 include U2AF35and NEMO/IKKγ (Okuda
et al., 2005; Ashida et al., 2010). Pull down assays confirmed
IpaH9.8 and U2AF35 binding, which specifically occurs at the C-
terminus of IpaH9.8 and 107–197 residues on U2AF35 (Okuda
et al., 2005). Binding of IpaH9.8 to NEMO/IKKγ requires an
ABIN-1 (A20 Binding Inhibitor) adaptor, as ABIN-1 knockdown
leads to lack of IpaH9.8-induced effect on NEMO levels (Ashida
et al., 2010). Ubiquitination of both U2AF35 and NEMO/IKKγ
mediated by IpaH9.8 leads to their degradation in a proteasome-
dependent manner (Figure 7) (Ashida et al., 2010; Perrett et al.,
2011). Seyedarabi et al. (2010) describe how IpaH9.8 domain
swapping occurs in response to host cell damage and this leads
to dimerization and inactivation of its E3 ubiquitin ligase activity.
Shigellamay therefore sense the host cell conditions tomaintain a
suitable environment for its continued proliferation and survival.
IpaH0722: Inhibits NFκB Activation
IpaH0722 is encoded on the Shigella chromosome. In an ipaH-
null mutant, whereby all seven of the chromosomal ipaH family
genes were deleted, there was an increase in the severity of
inflammation in the murine lung model in comparison to wild-
type Shigella infection (Ashida et al., 2007). When individual
ipaH knockouts were examined, it was found that IpaH0722
plays a role in dampening the inflammatory response, as an
ipaH0722− knockout had increased levels of IκBα degradation
leading to NFκB activation (Ashida et al., 2013). IpaH0722
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is also an E3 ubiquitin ligase, with the conserved CTR and
crucial cysteine residue that is found in other IpaH proteins.
A cysteine-to-alanine substitution increased NFκB activation,
indicating that the E3 ubiquitin ligase activity is crucial for
downregulation of NFκB (Ashida et al., 2013). Pull down assays
showed that IpaH0722 could bind to TRAF2, however a CTR-
truncation was unable to interact with TRAF2, further indicating
the importance of IpaH0722 ubiquitin ligase activity (Ashida
et al., 2013). IpaH0722 causes increased TRAF2 degradation
leading to a reduction in NFκB activity, thereby dampening the
host inflammatory response (Figure 7).
IpgD: Activates Akt/PI3K Signaling Pathway
IpgD-mediated increase of PtdIns(5)P has been shown to induce
Akt phosphorylation through activation of phosphatidylinositol
3-kinase (PI3K) (Mayo and Donner, 2001). An ipgD− knockout
has abolished Akt phosphorylation, which also occurs if
PtdIns(5)P is sequestered or phosphorylated to PtdIns(4,5)P2
(Pendaries et al., 2006). Reduction in Akt phosphorylation
was correlated with an increase in apoptosis and decreased
phosphorylation of Mdm2, the negative regulator of p53, by
the Akt serine-threonine kinase (Mayo and Donner, 2001).
Bergounioux et al. (2012) showed that an ipgD− mutant had
a reduction in early phase Mdm2 phosphorylation, causing a
delay in p53 degradation and increased apoptotic phenotype.
The Salmonella homolog SopB and SigD also have pro-survival
functions through interactions with Akt and activation of
the PI3K-Akt survival pathway (Steele-Mortimer et al., 2000;
Knodler et al., 2005).
Macrophage Vacuolar Rupture and
Pyroptosis
IpaC: Rupture of Phagocytic Vacuole
IpaC interacts with IpaB at the tip of the T3SS needle to form
a translocon that inserts into lipid membranes (Blocker et al.,
1999). An ipaC− mutant has no haemolytic activity and is unable
to escape the phagocytic vacuole (Bârzu et al., 1997). Given the
role determined for IpaC in lysis of the invasion vacuole in
epithelial cells (Osiecki et al., 2001; Du et al., 2016), it is very
likely that IpaC also plays a role in this process in macrophages
(Figure 1, step 3). Salmonella-induced vacuoles in macrophages
have an acidic pH, and it was proposed that acidification may
also be the cue to change IpaC function from cell entry to
membrane lysis (De Geyter et al., 1997). If acidification is not
the cue for vacuolar lysis, blocking acidification of endosomes
using Bafilomycin-A1 should not prevent Shigella from exiting
the vacuole.
IpaB: Promotes Macrophage Pyroptosis
IpaB’s hydrophobic region (310–430 amino acid residues) has
65% sequence identity to Salmonella invasive protein B (SipB),
and is involved in invasion of the epithelium via translocon
formation, phagosome escape, and induction of macrophage
pyroptosis (Guichon et al., 2001). The binding site for the
pro-pyroptotic and pro-inflammatory caspase-1, also known as
interleukin-1β converting enzyme (ICE), is located at residues
311–401 within the hydrophobic region (Guichon et al., 2001).
IpaB is localized at the bacterial surface and in discrete aggregates
in the macrophage cytoplasm, which suggests that IpaB interacts
with caspase-1 after vacuolar lysis rather than being injected into
the cytoplasm from the vacuole (Thirumalai et al., 1997). The
IpaB-ICE complex cleaves the precursors of pro-inflammatory
cytokines IL-1β and IL-18 to produce mature IL-1β and IL-18,
which are released in parallel to the induced pyroptosis (Figure 1,
steps 4, 6). IpaB may also promote macrophage pyroptosis by
allowing delivery of the T3SS the needle and rod proteins,
MxiI and MxiH, into the cytosol. These bind the NAIP family
of inflammasome receptors that trigger activation of caspase-
1 (Yang et al., 2013; Suzuki et al., 2014b). Recent work also
suggests that IpaD promotes macrophage apoptosis independent
of caspase-1 but via host caspases accompanied by mitochondrial
disruption (Arizmendi et al., 2016).
IpaH7.8: Promotes Macrophage Pyroptosis
IpaH7.8 is part of the ipaH gene family found on the Shigella
virulence plasmid. It was suggested that IpaH7.8 had a role in
vacuolar lysis as an ipaH7.8− mutant show reduced from escape
the phagocytic vacuole (Fernandez-Prada et al., 2000). However,
how this mutant strain (PWR700) was made is unclear, and its
complementation was poor. Paetzold et al. (2007) then described
how an ipaH7.8− knockout was able to escape the phagosome.
Therefore, IpaH7.8 has no role in vacuolar escape. Instead, the
IpaH7.8 E3 ubiquitin ligase targets glomulin, an inhibitor of
inflammasome activation, for ubiquitination leading to glomulin
degradation. Macrophage-specific cell death (Figure 1, step 6) is
then triggered through activated inflammasomes (Suzuki et al.,
2014a).
Modulation of Adaptive Immune System
LPS—Serotype Conversion and
Thymus-Independent T-cell Activation
The acquisition of the SHI-O PAImeans that Shigella is capable of
modifying its LPS (Figure 8). As humoral immunity is serotype
specific, and protection against re-infection is often unsuccessful
because of the variety of Shigella serotypes. Furthermore, O-
antigen of LPS is a carbohydrate, thymus-independent type 1
(TI-1) antigen, which activates B-cells in the absence of helper
T-cells (Murphy, 2012). The lack of helper T-cell involvement
means that these activated B-cells cannot undergo class switching
or develop a memory B-cell response to protect against re-
infection. At a low concentration of TI-1 antigens, such as
when LPS molecules are released from damaged bacteria, the
naïve B-cells are activated due to specific binding of their B-
cell receptors to the antigen (i.e., O-antigen of LPS). This
induces the production of O-antigen-specific antibodies, which
are protective against Shigella infection, however they are not
long-lasting and are overcome by serotype conversion. A high
concentration of TI-1 antigens, like the O-antigen on LPS at the
bacterial surface, leads to non-specific polyclonal activation of B
cells and the production of non-specific and hence likely non-
protective antibodies (Murphy, 2012). Thus, O-antigen behaves
as an “immunological decoy” at more than one level, making it a
particularly poor choice as a vaccine antigen.
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FIGURE 8 | S. flexneri serotype composition and conversion. LPS
O-antigen modifications include glucosylation (the addition of glucosyl groups),
mediated by the gtr operon and the addition of O-acetyl groups, achieved by
the O-acetyltransferase protein encoded by the oac gene. This is the basis of
serotype conversion, as Shigella begins with serotype Y and the basic
O-antigen structure, and further modification produces different serotypes
(Allison and Verma, 2000).
IpgD: Interferes with T-Lymphocyte Migration
IpgD is capable of interfering with T-cell migration by de-
phosphorylating PtdIns(4,5)P2 (Figure 9). Wild-type Shigella
causes a 50% decrease in T-cell migration toward a chemokine,
such as CXCL12 (Konradt et al., 2011). Cells transfected with
IpgD-GFP and incubated with CXCL12 had no ERM protein
localization at the pole, preventing T-cell polarization and
migration (Konradt et al., 2011). Mean velocity of T-cells
was measured in vivo, with uninfected T-cells exhibiting 9
and 4µm/min for wild-type Shigella-infected T-cells (Salgado-
Pabón et al., 2013). This indicates that Shigella is capable of
affecting T-cells in the context of infection, and that this ability
is dependent on IpgD. Shigella may prevent T-cell migration
and recruitment to areas of infection as they could be primed
by CD1 antigen-presenting cells, which are involved in the
presentation of lipid antigens, including LPS (Murphy, 2012).
This could induce a specific antigen-response as priming of T-
cells leads to stimulation of B-cells for isotype switching and
immunological memory, therefore it is advantageous to prevent
T-cell involvement in the adaptive immune response. Reducing
migration of CD8+ cytotoxic T-cell may also slow clearance of
infected cells from the epithelium.
IpaD: Promotes B-Lymphocyte Apoptosis
To prevent an antibody response to the LPS, specific or non-
specific, and production of immunological memory, Shigella
FIGURE 9 | IpgD inhibits T-cell migration and IpaD induces B-cell
apoptosis. (A) The PIP2 concentration at the plasma membrane is
responsible for the dynamic interchange between active and inactive
conformations of ezrin, radixin, and moesin (ERM) proteins (Konradt et al.,
2011). ERM proteins are involved in cell-cortex organization of T-cells, and
their active conformations localize at the membrane in response to chemokine
stimulation to allow T-cell migration toward chemoattractants (Konradt et al.,
2011). In the subcapsular sinus of the lymph node (Salgado-Pabón et al.,
2013) Shigella can invade T-cells or inject IpgD via the T3SS into T-cells to
reduce PtdIns(4,5)P2 concentration. This prevents cell polarisation induced by
active ERM proteins and T-cell migration to sites of infection (Konradt et al.,
2011). (B) Bacterial co-signals increase pro-apoptotic proteins, induce loss of
mitochondrial membrane potential (MMP), and also upregulate tlr2 mRNA,
leading to increased TLR2 expression on the surface of the cell. IpaD signaling
via the TLR2-1 heterodimer leads to up-regulation of FAS-associated death
domain (FADD) protein, which ultimately induces B-cell apoptosis (Nothelfer
et al., 2014).
also induces apoptosis in B-cells. This is mediated by IpaD
in a manner independent of Shigella invasion and effector
injection (Nothelfer et al., 2014). Incubation of B-cells with
IpaD alone does not induce cell death, and it was deduced
that bacterial co-signals work in conjunction with IpaD to
mediate B-cell apoptosis (Figure 9) (Nothelfer et al., 2014).
When anti-IpaD antibodies are applied to rectal biopsies of
shigellosis patients, they are visualized within isolated lymphoid
follicles and are contacting B-cells, suggesting that IpaD-
induced B-cell apoptosis occurs in vivo (Nothelfer et al.,
2014).
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DISCUSSION
How Do the Virulence Factors Work
Together?
Epithelial Barrier Destabilization and Fluid Secretion
Causes Severe Intestinal Inflammation and Diarrhoea
Once ingested, S. flexneri 2a delivers ShET1 in the jejunum
to elicit fluid secretion (Fasano et al., 1997). Other Shigella
species that harbor ShET2 require activation of the T3SS for
its secretion and this most likely occurs later after contact
with the colonic epithelium (Farfán et al., 2011). Pic and
SigA, also harbored by S. flexneri 2a species, act within the
lumen of the colon, on the apical side of the epithelium. Pic
degrades the thick mucus layer by its mucinolytic activity to
give Shigella better access to the epithelium (Gutierrez-Jimenez
et al., 2008). SigA mediates enterotoxic activity similar to ShET1
(Al-Hasani et al., 2000) and may have cytopathic effects to
initially destabilize the epithelial barrier (Al-Hasani et al., 2009).
SepA causes fluid secretion in S. flexneri 5a (Benjelloun-Touimi
et al., 1995). Shigella traverses the epithelium via M cells, and
reaches the basolateral surface of the epithelium. Here the
T3SS is activated, and Shigella can produce ShET2 to induce
further fluid secretion (Nataro et al., 1995). Other T3SS effectors,
including OspB (Zurawski et al., 2009; Ambrosi et al., 2014),
OspC1 (Zurawski et al., 2006), and OspZ (Zurawski et al.,
2008) (in S. flexneri) are secreted to phosphorylate and activate
MAPK pathways. Consequently, increased apical secretion of
the chemoattractant IL-8 causes PMN leukocytes to migrate
across the epithelium in a basolateral to apical direction. This
destabilizes the epithelial barrier, and the remaining bacteria at
the apical surface can access the basolateral surface. Shigella that
are phagocytosed by macrophages mediate pyroptosis via IpaB,
T3SS components and probably LPS, which bind and activates
caspase-1 (Thirumalai et al., 1997), and IpaH7.8 E3 ubiquitin
ligase, which targets glomulin, an inflammasome inhibitor, for
degradation (Suzuki et al., 2014a). Pyroptosis leads to release
of pro-inflammatory cytokines IL-1β and IL-18, which further
recruit PMN leukocytes and increase inflammation. All of these
virulence determinants and effectors are therefore involved in
the characteristic inflammation seen in shigellosis, including
the watery diarrhea seen in the early stages. In S. flexneri 2a
infection, mucus and blood may also be present due to the mucin
secretagogue activity of Pic, and the cytopathic effects of SigA.
Shiga toxin, found only in S. dysenteriae, may cause severe bloody
dysentery by damaging the vascular endothelium of the colon
(Fontaine et al., 1988).
Adhesion and Entry to Epithelium Causes an
Epithelial Genotoxic Stress Response
At the basolateral surface, glucosylation of the LPS is induced by
an unknown trigger, and allows the T3SS to access the epithelium
for activation (West et al., 2005). IpaB at the tip of the T3SS needle
complex may bind to CD44 lipid microdomains to maintain
contact of the T3SS with the epithelial cell (Skoudy et al., 2000),
and IcsA increases polar adhesion (Brotcke Zumsteg et al., 2014).
IpaB is inserted into the epithelial membrane, activating IpaD
and leading to recruitment of IpaC to the host membrane to
form the translocon pore (Blocker et al., 1999). IpaD activation
also signals for the T3SS to facilitate early effector translocation
through the T3SS needle and into the epithelial cell (Roehrich-
Doenitz et al., 2013). IpaC, as one of the immediate effectors
accessing the epithelial cell, mediates actin polymerization, either
independently or indirectly via Cdc42 and Rac1 (Tran Van Nhieu
et al., 1999; Mounier et al., 2009). This initiates membrane
ruﬄes and entry foci, further promoted by IpgB1 and IpgB2,
which remodel actin and the host cytoskeleton via their GEF
activity (Huang et al., 2009). IpaA, in conjunction with host
proteins, facilitates actin depolymerization, interfering with focal
adhesions and preventing uncontrolled actin polymerization by
IpaC (Tran Van Nhieu et al., 1997; Bourdet-Sicard et al., 1999).
IpgD converts PtdIns(4,5)P2 to PtdIns(5)P, which reduces the
membrane tether force and further stimulates membrane ruﬄe
formation (Niebuhr et al., 2002). Together these effectors mediate
the trigger mechanism for Shigella uptake into non-phagocytic
epithelial cells. Upon enclosure in the primary entry vacuole,
Shigella mediates membrane lysis. This involves primarily IpaB
and/or IpaC in the translocon pore (Osiecki et al., 2001; Du et al.,
2016), and as accessory processes IpgD-mediated recruitment of
Rab11 to macropinosomes which make contact with the entry
vacuole (Weiner et al., 2016), and/or VirA preventing growth of
the vacuole membrane (Mellouk et al., 2014).
Intercellular Spread and Immune Evasion Causes
Erratic Epithelial Destruction and Prevention of
Immunological Memory
Once inside the epithelial cytoplasm, Shigella uses VirA and IpaJ
to inactivate mainly Rab1 and ARF6, respectively. This halts ER-
to-Golgi traffic, preventing autophagic membrane formation and
inducing Golgi fragmentation (Dong et al., 2012; Burnaevskiy
et al., 2013, 2015). Shigella further prevents autophagy using IcsB
to mask the Atg5 binding site on IcsA (Ogawa et al., 2005).
Unipolar localization of IcsA at the Shigella old pole, possibly
achieved by LPS and IcsP, is crucial for efficient unidirectional
movement (Monack and Theriot, 2001) and allows Shigella to
move through the epithelial cytoplasm until it makes contact with
the inner surface of the plasma membrane. It then protrudes into
the adjacent epithelial cell, forming a secondary entry vacuole
consisting of a double membrane. This is subsequently lysed
by an unknown mechanism to allow access into the adjacent
epithelial cell cytoplasm. Remaining within the epithelial layer
is important for renewing the Shigella replication niche and also
evading immune detection. Evasion of the immune response is
achieved by T3SS effectors that inhibit activation pathways of
NFκB, including OspG (Kim et al., 2005), OspI (Sanada et al.,
2012), OspZ (Newton et al., 2010), IpaH9.8 (Ashida et al., 2010),
and IpaH0722 (Ashida et al., 2013). Degradation of the pro-
apoptotic factor p53 is achieved by IpgD (Mayo and Donner,
2001). Inhibition of the innate immune response also prevents
development of an adaptive immune response. The movement
of Shigella through the epithelium and the subsequent necrotic
epithelial cell death is the cause of the colonic destruction and
abdominal pain in shigellosis patients, contributing to prevention
of fluid absorption and dysentery containing blood.
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Virulence Determinants in
Disease-Causing Species
S. flexneri has a relatively stable genome, and acquired the
virulence plasmid early in its evolution. S. flexneri is capable of
persisting in water for several months, similarly to Vibrio cholera
(Faruque et al., 2002). This may explain its epidemiological
prevalence, as access to human hosts for months at a time
could facilitate the endemics seen in countries with poor water
sanitation. Speculatively, it may cause the most disease as
S. flexneri 2a harbors the SHI-1 PAI, which encodes Pic, SigA, and
ShET1. Pic may confer an advantage for scavenging nutrients,
therefore other strains may have a metabolic disadvantage when
compared to S. flexneri (Henderson et al., 1999; Harrington et al.,
2009). The importance of Pic and ShET1 in pathogenesis has
also been highlighted by Kotloff et al. (2004). The deletion of
pic and set1AB, in addition to ospD3, in a guanine autotrophic
(guaAB−) background produced an increasingly attenuated
vaccine, with none of the 14 volunteers developing diarrhea
(Kotloff et al., 2004). The truncated OspZ found in S. flexneri has
a pro-inflammatory role, compared to its anti-inflammatory in
the remaining sub-species, which may confer an inflammatory
advantage for initial establishment of infection (Zurawski et al.,
2008).
S. sonnei causes endemics in industrialized countries. Its
emergence was defined by its acquisition of the pINVB plasmid,
which harbors genes for the Plesiomonas shigelloides-related
serotype 17 O-antigen (Shepherd et al., 2000). P. shigelloides,
similarly to S. flexneri, can contaminate and persist in water
sources. Infection with P. shigelloides from contaminated water
may protect human hosts from established S. sonnei infection
due to immunological memory and cross-reactive antibodies to
the identical O-antigen (Sack et al., 1994). This hypothesis could
also explain why an improvement in water sanitation causes
a decrease in S. flexneri infection but an increase in S. sonnei
infections, as there is no previous infection with P. shigelloides
from contaminated water to induce a protective immunological
memory response. Direct transmission of S. sonnei in schools
and care settings is also capable of maintaining endemics in
communities, without the requirement of an environmental
reservoir.
S. dysenteriae infection is the most severe, which has
been linked to the effects of the Shiga toxin harbored by
S. dysenteriae type 1. There is no known natural reservoir
for S. dysenteriae, and it causes sporadic epidemics linked to
poor hygiene and overcrowding. The Shiga toxin does not
play a role in the intracellular infection, but can stimulate
the recruitment of PMN leukocytes and damages the colonic
vascular endothelium, leading to the characteristic blood-
containing dysentery (Fontaine et al., 1988). It has been suggested
that, like Salmonella enterica serovar Typhi, S. dysenteriae
can be maintained and transmitted within a community by
an asymptomatic carrier. Long term carriers with attenuated
symptoms have been previously reported (Levine et al., 1973;
Clements et al., 1988), and this may explain the epidemiology of
S. dysenteriae epidemics, which disappear to then reappear years
later, and are also transferred intercontinentally (Rohmer et al.,
2014).
S. boydii causes the least burden of disease worldwide. It
represents 1–2% of Shigella isolated, and is mostly confined to
the Indian subcontinent. In 2000, S. boydii serotype 20 was
discovered. Its transmission was linked to travel in Mexico
(Kalluir et al., 2004) and it was themost frequent agent of S. boydii
infection in Canada (Woodward et al., 2005). However, S. boydii
still only caused 1% of Shigella infections in the United States
compared to the 77% of infections caused by S. sonnei (Kalluir
et al., 2004). Due to the diversity of S. boydii serotypes, and its
lack of clinical relevance there is little known about its virulence
determinants and why it causes less disease than S. flexneri,
S. sonnei, and S. dysenteriae.
Effector Interplay
Multiple Effectors for One Target Pathway
Effector-Triggered Immune Pathology (ETIP) is an advanced
model of both the Guard Hypothesis and Effector-Triggered
Immunity (ETI). If the host is “resistant” and encodes the
guardee protein, it is capable of recognizing the damage
mediated by Shigella effectors and this induces an efficient
innate immune response. Shigella can use this to its advantage,
increasing intestinal inflammation which is required for infection
establishment and transmission by diarrhea (Stuart et al., 2013).
However, this inflammation eventually leads to the clearance of
infection, therefore Shigella harbors a large repertoire of anti-
inflammatory mechanisms for down-regulation of ETIP. The
host is not able to “guard” all the steps/signaling pathways
involved in NFκB activation, therefore multiple effectors
with different biochemical functions are capable of efficiently
interfering with these pathways and dampening the host immune
response. Similarly, VirA and IpaJ act to fragment the Golgi via
exertion of differing biochemical activities on different small GTP
binding proteins involved in its maintenance.
More Than One Effector with a Similar Biochemical
Function
IpgB1 and IpgB2 are similar in their WxxxE motif and
GEF activity, but they have non-overlapping substrates. Only
a dual ipgB1−ipgB2− knockout had a negative Sereny test,
indicating that they also have similar but non-overlapping
functions (Hachani et al., 2007). Lack of redundancy was also
confirmed, as an ipgB2− knockout has the same phenotype
as the wild-type strain, however the ipgB1− knockout had an
increase in inflammation compared to the wild-type strain.
This may link to the guard hypothesis, whereby IpgB1 prevents
detection of IpgB2 by the host guardee proteins, perhaps via its
own non-overlapping enzyme activity, to prevent an excessive
inflammatory response.
One Effector with Multiple Functions?
An effector characterized with multiple roles in pathogensis
is normally due to a single function which mediates several
effects. For example, the only characterized activity of IpgD is
that it dephosphorylates phosphoinositides, decreasing levels of
PtdIns(4,5)P2 and increasing levels of PtdIns(5)P. Changes in
the intracellular concentrations of these phosphoinositides then
produces effects directly, such as membrane ruﬄes (Niebuhr
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et al., 2002), or indirectly, such as vacuolar lysis (Mellouk et al.,
2014), activation of Akt/PI3K signaling pathway (Pendaries et al.,
2006), and interference with T-lymphocyte migration (Konradt
et al., 2011). Therefore, IpgD has one biochemical activity,
which mediates multiple effects on the host cell. This is also
probably the case for IpaJ in Golgi fragmentation and STING
activation and for OspB in modulating cell-to-cell spread via
mTOR and ERK/MAPK signaling. Some factors, such as IcsA
involved in adhesion and actin-tail formation, may genuinely
have two very different biochemical functions, used at different
points in the infectious cycle. OspE1/E2 seem involved in
adhesion to host cells and stability of tight junctions. However,
others may not. At its position at the T3SS needle tip, IpaB
is involved in CD44 interactions (Skoudy et al., 2000), host
cell sensing, translocon pore formation (Blocker et al., 1999),
and directly or indirectly, and lysis of the single and double
membrane entry vacuoles (High et al., 1992; Page et al., 1999).
Once secreted, IpaB plays a role in macrophage pyroptosis
(Guichon et al., 2001) and cell cycle arrest (Iwai et al., 2007).
It is difficult to comprehend how IpaB could exert all these
functions without possessing multiple biological activities, which
remain unclear. However, some of these functions may have been
misattributed to IpaB due to pleotropic effects stemming from its
involvement in translocon formation, which is crucial for Shigella
entry.
CONCLUDING REMARKS
The vast majority of the functional work presented here has
been done on S. flexneri. Comparative analysis of the dominant
Shigella genomes causing disease is required for further analysis
of virulence determinants, such as any involved lysis of the
single and double membrane entry vacuoles, which remain
completely unclear, and of their epidemiological consequences.
The importance of such genomic investigations has recently
been highlighted (The et al., 2016). Identification of important
and conserved effectors and other virulence determinants that
cause disease will contribute to an overall understanding of
infection, further illuminating species tropism and transmission
and helping to create a pan-Shigella vaccine, which so far has been
unsuccessful.
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